SCHEMBL21318973

SCHEMBL21318973

CCCSc1nc(Cl)c(NC)c(N(C=O)Cc2cncnc2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319065 0.85 MEN1 (0.36) —
SCHEMBL21318942 0.84 KMT2A (0.34) —
SCHEMBL21319054 0.82 ADORA3 (0.43) —
SCHEMBL21318981 0.82 TOP2A (0.33) —
SCHEMBL21318947 0.74 USP28 (0.39) —
SCHEMBL19945665 0.73 ABCB1 (0.38) —
SCHEMBL21318940 0.73 ADORA3 (0.42) —
SCHEMBL19945779 0.72 MEN1 (0.36) —
SCHEMBL21318976 0.72 ADORA3 (0.37) —
SCHEMBL21318984 0.72 KMT2A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294740-B1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback